Abstract:Background and Aims The role of vascular smooth muscle cells (SMCs) in atherosclerosis has evolved to indicate causal genetic links with the disease. Single cell RNA sequencing (scRNAseq) studies have identified multiple cell populations of mesenchymal origin within atherosclerotic lesions, including various SMC sub-phenotypes, but it is unknown how they relate to patient clinical parameters and genetics. Here, mesenchymal cell populations in atherosclerotic plaques were correlated with major coronary artery disease (CAD) genetic variants and functional analyses performed to identify SMC markers involved in the disease. Methods Bioinformatic deconvolution was done on bulk microarrays from carotid plaques in the Biobank of Karolinska Endarterectomies (BiKE, n = 125) using public plaque scRNAseq data and associated with patient clinical data and follow-up information. BiKE patients were clustered based on the deconvoluted cell fractions. Quantitative trait loci (QTLs) analyses were performed to predict the effect of CAD associated genetic variants on mesenchymal cell fractions (cfQTLs) and gene expression (eQTLs) in plaques. Results Lesions from symptomatic patients had higher fractions of Type 1 macrophages and pericytes, but lower fractions of classical and modulated SMCs compared with asymptomatic ones, particularly females. Presence of diabetes or statin treatment did not affect the cell fraction distribution. Clustering based on plaque cell fractions, revealed three patient groups, with relative differences in their stability profiles and associations to stroke, even during long-term follow-up. Several single nucleotide polymorphisms associated with plaque mesenchymal cell fractions, upstream of the circadian rhythm gene ARNTL were identified. In vitro silencing of ARNTL in human carotid SMCs increased the expression of contractile markers and attenuated cell proliferation. Conclusions This study shows the potential of combining scRNAseq data with vertically integrated clinical, genetic, and transcriptomic data from a large biobank of human plaques, for refinement of patient vulnerability and risk prediction stratification. The study revealed novel CAD-associated variants that may be functionally linked to SMCs in atherosclerotic plaques. Specifically, variants in the ARNTL gene may influence SMC ratios and function, and its role as a regulator of SMC proliferation should be further investigated.

Abstract 009: Ribosomal Profiling of Vascular Smooth Muscle Cells in Vivo Identifies Cell-type Specific Transcripts and Enrichment of Blood Pressure Associated Genes

Discovery of an Evolutionarily Conserved Smooth Muscle Cell-Specific Lncrna CARMN

Abstract 11993: Integrative Analysis of Single-Cell Transcriptomics and Polygenic Risk Scores Uncovers Vascular Smooth Muscle Cell Heterogeneity in Human Aortic Aneurisms

Abstract P353: Adipose-derived Stem Cells Contribute to Vascular Remodeling Via Clec11a + Subpopulation

Abstract 12723: Smooth Muscle-Derived CD34 + Cells after Vascular Injury Contribute to Vascular Remodeling

Discovery of an evolutionarily conserved smooth muscle cell-specific lncRNA<i>CARMN</i>

Abstract 709: Implementation Of Ribosomal Tagging Strategies To Analyze Smooth Muscle Specific Rna Expression In Mouse Models Of Atherosclerosis

Secreted Protein Profiling of Human Aortic Smooth Muscle Cells Identifies Vascular Disease Associations

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Single Cell Transcriptomic Analysis Identifies Novel Vascular Smooth Muscle Subsets under High Hydrostatic Pressure

Abstract P133: Human Induced Pluripotent Stem Cells-derived Vascular Endothelial and Smooth Muscle Cells and Fractions of Native Human Arterioles Exhibit Robust Expression of Marker Genes

Abstract 218: Integration Of Coronary Artery Disease GWAS With Bulk And Single-cell Transcriptomics From Atherosclerotic Plaques By Deconvolution, Reveals Novel Smooth Muscle Cell Genes

Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification

Abstract 067: Genome-wide Chromatin Conformation Map of Human Induced Pluripotent Stem Cell-derived Vascular Endothelial Cells Reveals New Regulatory Insights

Abstract 465: Integrative Single-cell Meta-analysis Reveals Disease-relevant Vascular Cell States and Markers in Human Atherosclerosis

A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease

Single-Cell Transcriptomics-Based Study of Transcriptional Regulatory Features in the Mouse Brain Vasculature

Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats

Translatome profiling reveals Itih4 as a novel smooth muscle cell-specific gene in atherosclerosis

A cell and transcriptome atlas of the human arterial vasculature